AAAAAA

   
Results: 1-9 |
Results: 9
Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues
Authors: Abgrall, S Charreau, I Joly, V Bloch, J Reynes, J Yeni, P
Citation: S. Abgrall et al., Risk factors for esophageal candidiasis in a large cohort of HIV-infected patients treated with nucleoside analogues, EUR J CL M, 20(5), 2001, pp. 346-349
An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methodsof the initio trial
Authors: Babiker, AG Darbyshire, JH Cooper, DA Hooker, MH Withnall, R Yeni, P
Citation: Ag. Babiker et al., An open-label randomized trial to evaluate different therapeutic strategies of combination therapy in HIV-1 infection: Design, rationale, and methodsof the initio trial, CONTR CL TR, 22(2), 2001, pp. 160-175
Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression
Authors: Rabaud, C Charreau, I Izard, S Raffi, F Meiffredy, V Leport, C Guillemin, F Yeni, P Aboulker, JP
Citation: C. Rabaud et al., Adverse reactions to cotrimoxazole in HIV-infected patients: Predictive factors and subsequent HIV disease progression, SC J IN DIS, 33(10), 2001, pp. 759-764
Non-nucleosidic reverse transcriptase inhibitors
Authors: Joly, V Yeni, P
Citation: V. Joly et P. Yeni, Non-nucleosidic reverse transcriptase inhibitors, ANN MED IN, 151(4), 2000, pp. 260-267
Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study
Authors: Masquelier, B Descamps, D Carriere, I Ferchal, F Collin, G Denayrolles, M Ruffault, A Chanzy, B Izopet, J Buffet-Janvresse, C Schmitt, MP Race, E Fleury, HJA Aboulker, JP Yeni, P Brun-Vezinet, F
Citation: B. Masquelier et al., Zidovudine resensitization and dual HIV-1 resistance to zidovudine and lamivudine in the Delta lamivudine roll-over study, ANTIVIR TH, 4(2), 1999, pp. 69-77
Nodular lesions of the liver revealing multiple myeloma
Authors: Chemlal, K Couvelard, A Grange, MJ Marmuse, JP Charneau, C Launay, O Carbon, C Yeni, P
Citation: K. Chemlal et al., Nodular lesions of the liver revealing multiple myeloma, LEUK LYMPH, 33(3-4), 1999, pp. 389-392
Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2
Authors: Zou, WP Foussat, A Houhou, S Durand-Gasselin, I Dulioust, A Bouchet, L Galanaud, P Levy, Y Emilie, D Aboulker, JP Capitant, C Boue, F Bouvet, E Karmochkinc, M Kazatchkine, M Oksenhendler, E Viard, JP Weiss, L Yeni, P Delfraissy, JF Goujard, C Jarrousse, B Lepeu, G Cartier, F Bazin, C Six, M Gastaut, JA Seligmann, M Herrerra, A Maral, J
Citation: Wp. Zou et al., Acute upregulation of CCR-5 expression by CD4+ T lymphocytes in HIV-infected patients treated with interleukin-2, AIDS, 13(4), 1999, pp. 455-463
HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study
Authors: Aboulker, JP Babiker, AG Brun-Vezinet, F Darbyshire, JH Flandre, P Gazzard, B Nunn, AJ Goodall, R Aber, V Bragman, K Breckenridge, AM Carbon, C Charreau, I Chene, G Collis, P Cooper, D Dormont, J Fiddian, P Flepp, M Goebel, FD Hooker, M Lange, J Luthy, R Peto, TEA Reiss, P Seligmann, M Stone, AB Thomis, J Vella, S Walckenaer, G Warrell, D Weller, IVD Wilber, R Yeni, P Yeo, J Withnall, R Goudsmit, J Huraux, JM van der Noorda, J Weiss, R Boucher, C Schuurman, R Descamps, D Jeffries, D Tedder, R Weber, J Krzyanowski, C Weverling, G
Citation: Jp. Aboulker et al., HIV-1 RNA response to antiretroviral treatment in 1280 participants in theDelta Trial: an extended virology study, AIDS, 13(1), 1999, pp. 57-65
Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence
Authors: Abrams, D Allan, D Antunes, F Breckenridge, A Bruun, J Cameron, W Carbon, C Chalmers, I Chang, H Chodakewitz, J Clendenin, N Clumeck, N Collier, A Collins, G Cooper, E Cooper, D Danner, S D'Aquila, R DeGruttola, V DeMasi, R Dee, L Deyton, L Dixon, D Farthing, C Feinberg, J Fischl, M Flepp, M Gartland, M Gatell, J Gazzard, B Goebel, F Gotzsche, P Gringeri, A Hall, D Hamilton, J Hammer, S Hartigan, P Heath-Chiozzi, M Henry, K Hill, A Hirschel, B Ioannidis, J Kahn, J Katlama, C Katzenstein, D Killen, J King, E de Loes, SK Kravcik, S Lange, J Leavitt, R Leonard, J Maeland, A Mannucci, P Mathiesen, L McDade, H Meibohn, A Melander, H Merigan, T Mulder, J Myers, M Neaton, J Nessling, M Perrin, L Pettinelli, C Phair, J Phillips, A Pinching, A Poppa, A Power, L Reiss, P Richman, D Rooney, J Rousseau, F Rutherford, G Salgo, M Sandstrom, E Saravolatz, L Savidge, G Schnittman, S Schooley, R Seligmann, M Simberkoff, M Skowron, G Slade, P Smith, D Smith, RP Soriano, V Stanley, K Stingl, G Stoffels, P Struthers, L Tierney, C Thompson, M Van der Broeck, R Van Leeuven, R Van Weverling, G Veenstra, J Vella, S Volberding, P Weber, J Winslow, D Yeni, P Yeo, J Dormont, J Sande, M Weller, I Babiker, A Collins, R Darbyshire, J Duncan, W Foulkes, M Hughes, M Peto, R Peto, T Walker, S
Citation: D. Abrams et al., Zidovudine, didanosine, and zalcitabine in the treatment of HIV infection:meta-analyses of the randomised evidence, LANCET, 353(9169), 1999, pp. 2014-2025
Risultati: 1-9 |